Home > Archive>Volume 11, Issue 7, 2011 >1176-1178. DOI:10.3969/j.issn.1672-5123.2011.07.015
PDF HTML XML Export Cite reminder
Research progress in model of retinopathy of prematurity
Author:
Clc Number:

R774.1

  • Article
    • | |
  • Metrics
    • |
  • Reference [23]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Currently, retinopathy of prematurity (ROP) has become a worldwide important cause of blindness in children, accounting for 6% to 18% of causes of blindness in children. It has become a global concern to improve the quality of life in preterm infants by controlling ROP. Therefore, the establishment of an appropriate animal model of retinal neovascularization has become an important means of discussing the pathogenesis of retinal neovascularization and assessing the effect of drug treatment. In this paper, a variety of models to simulate the process of ROP were reviewed.

    Reference
    1 Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35(1):101-111
    2 Pierce EA, Avery RL, Foley ED, et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995;92(3):905-909
    3 Wilkinson-Berka JL，Alousis NS，Kelly DJ, et al.COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity. Invest
    Ophthalmol Vis Sci 2003；44(3):974-979
    4 Blaschke AJ, Staley K,Chun J.Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. Development 1996;122(4):1165-1174
    5 Penn JS, Henry MM. Assessing retinal neovaseularization in an animal model of proliferative retinopathy. Microvasc Res 1996;51(1):126-130
    6 Spaide RF, Laud K，Fine HF, et al. Intravitreal bevaeizumab treatment of choroidal neovaseularization secondary to age-related maeular degeneration. Retina 2006;26(4):383-390
    7 Yano K，Brown LF, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 2001;107(4):409-417
    8 Anderson CG, Benitz WE, Madan A. Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. J Perinatol 2004;24(3):164-168
    9王玉环, 陈超,石文静，等.不同吸氧方式对新生鼠视网膜血管发育的影响.中国当代儿科杂志 2006；8（2）:129-132
    10忽俊，周晓东，龚红华，等.提前光照对氧诱导视网膜病小鼠模型的视网膜血管发育的影响.眼视光学杂志 2009；11（1）：42-49
    11 Goldberg I，Graham SL，Klistorner AI. Multifocal objective perimetry in the detection of glaucomatous field loss. Am J Ophthalmol 2002;133(1)：29-39
    12 Zhang S,Leske DA, Holmes JM. Neovascularization grading methods in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2000;41(3)：887-891
    13 Holmes JM, Zhang S, Leske DA, et al. Metabolic acidosis-induced retinopathy in the neonatal rat. Invest Ophthalmol Vis Sci 1999;40(3):804-809
    14 Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of crytherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization.
    Arch Ophthalmol 1996;114(4):417-424
    15 Browning J，Wylie CK，Gole G. Quantification of oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1997;38(6):1168-1174
    16于萍, 步宏,王华,等.免疫组化结果的图像分析与人工计数方法的对比研究.生物医学工程学杂志2003；20( 2) : 288- 290
    17 Fulton AB, Hansen RM, Moskowitz A. The cone electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci2008;49(2)：814-819
    18陈璐，郑微，王超英，等.早产儿全视野闪光视网膜电图检查.眼科研究2010；28（9）：873-877
    19刘玲,杨于嘉,彭隆祥,等.高压氧对新生鼠HIBD模型神经元线粒体的保护作用.小儿急救医学 2004；11 (6):363-365
    20朱春玲，李强，邓敏.高氧环境对新生未成熟大鼠视网膜超微结构的影响.眼科新进展 2007;27（7）：489-491
    21孟岩,仇宜解,赵桂秋,等.实验性玻璃体腔内高氧对视网膜超微结构的影响.眼科新进展 2002;22(2): 85-87·
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Xian-Ming Bai, Dan Zhu. ,/et al.Research progress in model of retinopathy of prematurity. Guoji Yanke Zazhi( Int Eye Sci) 2011;11(7):1176-1178

Copy
Share
Article Metrics
  • Abstract:1373
  • PDF: 146
  • HTML: 0
  • Cited by: 0
Publication History
You are the 26546 Visitors
Governing Body：Department of Health, Provincial Government of Shaanxi, China
Organizer：Xi'an Medical Association of China
Address：Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, China
Fax：(8629)82245172 Phone：(+8629)82245172/82210956
Email：ijopress@163.com
® 2025 All Rights Reserved   The terms of CC BY-NC-ND 4.0 are applicable to all open access content.